Denmark Home Healthcare Market Analysis Sample Report

Denmark Home
Healthcare Market
Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the Denmark Home
Healthcare Market and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, main players, growth and demand drivers,
challenges & future outlook, etc. This is one of the most comprehensive
reports about the Denmark Home Healthcare Market, and offers
unmatched value, accuracy, and expert insights

3
A Sample Report on Denmark Home Healthcare Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Home Healthcare Overview 12-24
1.1. Overview
1.2. Denmark Overview
1.3. Economic Overview: Denmark
1.4. Home Healthcare Market in Denmark
1.5. Healthcare Services Market in Denmark
1.6. Healthcare Scenario in Denmark
1.7. Health Insurance Coverage: Denmark
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting
2.1 Market size and forecasts (Excel and Methodology) 25-30

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Service Type
2.2.2. By Device Type
2.2.3. By Indication Type
3. Market Dynamics 31-35
3.1. Market Growth Drivers
3.1.1. Aging Population
3.1.2. Funding and Financial Support
3.1.3. Technological Advancements
3.2. Market Restraints
3.2.1. Workforce Challenges
3.2.2. Coordination and Integration with Other Healthcare Services

6
Table of Content
CONTENT PG. NO.
3.2.3. Limited Interoperability
4. Competitive Landscape 36-46
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Falck Healthcare
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. Attendo
4.2.2.1. Overview

7
Table of Content
CONTENT PG. NO.
4.2.3. Nordic Medicare
4.2.3.1. Overview
4.2.4. Sundhedsplejen
4.2.4.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.5. Privathospitalet Mølholm
4.2.5.1. Overview
4.2.6. Hjemmeplejen A/S
4.2.6.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.7. Dedicare Homecare
4.2.7.1. Overview
4.2.8. Liva Healthcare
4.2.8.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.9. Mediq Danmark
4.2.9.1. Overview
4.2.10. SeniorLiv
4.2.10.1. Overview

11
Table of Content
CONTENT PG. NO.
5. Reimbursement Scenario 47-54
5.1. Reimbursement Regulation in Denmark
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
5.4 Reimbursement Process – Medicare
5.5 Reimbursement Process - Medicaid
6. Methodology & Scope 55-60

Denmark Home Healthcare Market Analysis
1. Home Healthcare Overview

13
Overview of Global Home Healthcare Trends
▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Scope of Home Healthcare
70%
of the population
using home
healthcare services
are aged 65 and
older
One-third
of the persons requiring in-
home care are under age 60
$285 Mn
virtual reality in
medical and home
health technology
is valued at $285
Mn
42%
North America dominates the
global home healthcare share

14
1.1 Statistics at a Glance: Overviewof Home Healthcare in the World
(continued)
North America
~ Market Size of
$XX Bn
Europe
~Revenue to reach
$XX Bn by 2027
Asia
-Fastest CAGR
Denmark
~Market Size of
$XX Bn
Middle East
Market
~$XX Bn Market

15
1.2 Denmark Overview
5,935,619
Is the total
population of
Denmark in 2023
42.2 years
Is the median age
in Denmark
$390.677
Gross domestic
product (GDP) of
Denmark in 2022
$66,516
Gross domestic
product (GDP) per
capita of Denmark in
2022
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest

16
1.3 Economic Overview: Denmark
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Denmark, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Denmark, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

17
1.4 Overview of Home Healthcare in Denmark
Highlights of Home Healthcare in Denmark
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Denmark
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Municipalities are responsible for financing and delivering nursing home care, home
nurses, health visitors, some dental services, school health services, home help,
substance
Home care is organized and financed by the municipalities. Municipalities also fully finance
maternity care, preventive home visits for infants, and consultations for toddlers and
preschoolers
Denmark Pharmaceutical Association (KPA) is a professional group of regulated
pharmaceutical technologists with a membership of 7,500 of which 3,200 are community
pharmacists who either own or manage their stores
Denmark’s Pharmacy & Poisons Board (PPB) is actively involved in regulating and
enhancing the sector from a quality perspective, in 2011, for example, an estimated 20-
25% of drugs sold in the country were counterfeit

18
1.5 Healthcare Services in Denmark
XX XX XX XX XX XX XX XX XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Denmark Healthcare Services Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Healthcare Services market in Denmark, which includes the market size, current
trends and other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

19
1.6 Healthcare Scenario in Denmark
▪ Denmark's healthcare system is a mix of public and private providers. The Ministry of Health is responsible for policy formulation and overall
coordination of the sector
o Public healthcare services are offered through government hospitals, health centers, and dispensaries
o Private healthcare facilities are operated by non-governmental organizations (NGOs), faith-based organizations, and for-profit entities
▪ Denmark's healthcare system is a mix of public and private providers. The Ministry of Health is responsible for policy formulation and overall
coordination of the sector
▪ Universal Health Coverage (UHC): UHC program to provide affordable healthcare to all Denmarkn citizens. The aim is to gradually expand
coverage and reduce the financial burden of healthcare
▪ Healthcare Workforce Development: Steps have been taken to address the shortage of healthcare professionals by training and hiring
more doctors, nurses, and other healthcare workers. Additionally, efforts have been made to deploy health workers to rural areas
Regulatory
Authority
▪ Pharmacy and Poisons Board (PPB) is the regulatory authority responsible for ensuring the quality, safety,
and efficacy of pharmaceutical products in Denmark.
Drug Registration ▪ PPB is responsible for the registration of pharmaceutical products in Denmark
Procurement and
Distribution
▪ Public procurement and distribution of pharmaceutical products in Denmark are primarily managed by the
Denmark Medical Supplies Authority
Quality Control
▪ PPB conducts quality control inspections of pharmaceutical manufacturing facilities to ensure compliance with
Good Manufacturing Practices (GMP)
Pharmacovigilance
▪ In Denmark, the Pharmacovigilance Directorate under the Pharmacy and Poisons Board is responsible for
monitoring and reporting adverse drug reactions and ensuring the safety of pharmaceutical products
Key aspects related to pharmaceutical management in Denmark

20
1.7 Health Insurance Coverage: Denmark
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

21
1.8 Budget of Denmark Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

22
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

23
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Quipt Acquires Great
Elm's DME Business
Acquisition
$80 Mn
January
2023
▪ Quipt Home Medical Corp. has bought Great Elm Healthcare,
LLC, a division of Great Elm Group, Inc. that operates a
complete line of respiratory-related durable medical equipment
(DME) service locations across eight states in the Midwest,
Southwest and Pacific Northwest and had $60 million in revenue
last year
UnitedHealth acquired
LHC
Acquisition $5.4 Bn March 2022
▪ UnitedHealth announced in March that it planned to buy LHC for
$5.4 Bn in a move to offer more integrated care
▪ LHC, the Louisiana-based home health and hospice provider that
operates in 37 states and the District of Columbia, now becomes
part of Optum Health, UnitedHealth's care delivery and pharmacy
benefit manager and health care provider
Latest Deals in Home Healthcare: Global

24
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger -
Acquisition -
Illustrative
Latest Deals in Home Healthcare: Global

2. Market Size and Forecasting

26
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Denmark Home Healthcare Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
and other details related to the topic
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Denmark Patient Size
(Bn)
0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Denmark Market Size (Bn
$)
61 74 84 87 91 95 99 106
Illustrative

27
A Sample Report on Egypt Home Healthcare Market Analysis I Confidential
2.2 Snapshot of Home Healthcare Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Denmark Home Healthcare Market
Device Type
Testing, Screening, and
Monitoring Device
Therapeutic Home Healthcare
Devices
Mobility Assist
Service Type
Skilled Nursing Services
Rehabilitation Therapy Services
Hospice and Palliative Care
Services
Unskilled Care Services
Respiratory Therapy Services
Infusion Therapy Services
Pregnancy Care Services
Indication Type
Cardiovascular Disorders &
Hypertension
Diabetes
Respiratory Diseases
Pregnancy
Mobility Disorders
Hearing Disorders
Home Healthcare
Wound Care

28
Denmark Home Healthcare Market Share, By Device Type (2022)
Testing,
Screening, and
Monitoring
Device
Therapeutic
Home Healthcare
Devices
Mobility Assist
▪ Testing, screening and monitoring
device market in Denmark is a
significant component of the overall
home healthcare treatment market
final report
2.2.1 Market Segmentation: By Device Type
Illustrative

29
Denmark Home Healthcare Market Share, By Service Type (2022)
Skilled Nursing
Services
Rehabilitation
Therapy
Services
Hospice and
Palliative Care
Services
Unskilled Care
Services
Respiratory
Therapy
Services
Infusion Therapy
Services
Pregnancy Care
Services
2.2.2 Market Segmentation: By Service Type
▪ Skilled nursing services market in
Denmark is a significant component of
the overall home healthcare market
final report
Illustrative

30
Denmark Home Healthcare Market Share, By Indication Type (2022)
2.2.3 Market Segmentation: By Indication Type
▪ Cardiovascular disorders and
hypertension have the maximum
market share in Denmark home
healthcare market with approximately
xx%
final report
Cardiovascular
Disorders &
Hypertension
Diabetes
Respiratory
Diseases
Pregnancy
Mobility
Disorders
Hearing Disorders
Cancer Wound Care
Illustrative

3. Market Dynamics

32
3.1 Market growth drivers
▪ Denmark, like many other developed countries, has an aging population.
As people live longer, there is an increased demand for healthcare
services, including home healthcare, to support the elderly population's
healthcare needs
▪ This demographic trend is a significant driver for the growth of the home
healthcare market in Denmark
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.1 In 2022, population aged 65 years and above for Denmark was 20.5 %. Population aged 65 years and above of
Denmark increased from 12.9 % in 1973 to 20.5 % in 2022 growing at an average annual rate of 0.95%
Rising Aging Population

33
▪ Danish government has implemented various initiatives to promote home healthcare and support the aging population
▪ These initiatives aim to provide high-quality care at home, reduce healthcare costs, and alleviate the burden on hospitals and nursing
homes. It also support in funding to play a crucial role in driving the growth of the home healthcare market
▪ Danish government promotes care coordination and case management to ensure seamless delivery of healthcare services at home.
This involves creating multidisciplinary care teams that include healthcare professionals such as doctors, nurses, physiotherapists,
and social workers. These teams work together to develop personalized care plans, coordinate services, and monitor the patient's
health and well-being
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will
be presented in the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
3.1.2 Danish government allocates funds and provides financial support to promote home healthcare services. This
includes subsidies and reimbursements for home healthcare expenses, making it more affordable for individuals to
receive care at home.

34
▪ Advancements in technology have revolutionized the healthcare industry, including home healthcare. Technological innovations such
as telemedicine, remote patient monitoring devices, wearable sensors, and mobile health applications have made it easier to provide
healthcare services at home
▪ These technologies improve patient outcomes, enhance efficiency, and increase the accessibility of healthcare services, thereby
driving the growth of the home healthcare market
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will
be presented in the final report
3.1.3 Danish government is one of the few (and one of the first) countries to establish a national agency for e-health
under the Ministry of Health. For more than 25 years, Denmark has seen a significant rollout of IT services within the
whole healthcare sector with the hospitals, general practitioners and municipalities leading the way

35
3.2 Market restraints
3.2.1 Denmark faces GP shortages –
particularly in rural and remote
areas. In 2019, only 37% of GPs
were accepting new patients, down
from 51% in 2015
▪ Shortage of healthcare
professionals, including nurses,
doctors, and therapists, is a
significant restraint in the home
healthcare market
▪ Demand for home healthcare
services often exceeds the
availability of skilled healthcare
workers
▪ This shortage can limit the
number of patients who can be
served and put strain on the
existing workforce, potentially
affecting the quality and
timeliness of care
3.2.2 Healthcare system often
consists of various entities,
including hospitals, primary care
clinics, home healthcare agencies,
and social care organizations
▪ Effective coordination and
integration between home
healthcare providers and other
healthcare services, such as
hospitals, primary care, and
social care, are essential for
seamless patient care
▪ This can lead to inefficiencies,
gaps in care, and reduced
patient satisfaction
3.2.3 Interoperability refers to the
ability of different healthcare
systems and EHRs to exchange
and interpret health information
accurately
▪ Lack of interoperability can
hinder the seamless flow of
patient information between
different care settings, making it
difficult for healthcare providers
to have a comprehensive view of
the patient's medical history,
ongoing treatments, and care
plans
▪ This can lead to inefficiencies,
delays, and potential errors in
care delivery
Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth.

4. Competitive Landscape

37
4.1 Major Market Share
▪ Denmark Home Healthcare Market is a
highly competitive space, with many
companies developing and marketing
Home Healthcare treatments
▪ Some of the top companies in Denmark
Home Healthcare Market based on
revenue and market share include
interest
Revenue of Major players in Denmark Home Healthcare Market ($ Mn)
XX
Company10
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Illustrative

38
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 Falck Healthcare
3 Nordic Medicare
5 Privathospitalet Mølholm
7 Dedicare Homecare
9 Mediq Danmark
2 Attendo
4 Sundhedsplejen
6 Hjemmeplejen A/S
8 Liva Healthcare
SeniorLiv
10
Key Note:

39
4.2.1 Falck Healthcare
Founded in: 1906
HQ: Copenhagen, Denmark
Type: Private
Revenue: $70.88 Bn
Website: www.falck.com
▪ Falck A/S is a Danish organization with activities in most areas
of Europe and representation on five continents
▪ Falck is a well-established provider of healthcare services,
including home healthcare, in Denmark
▪ They offer a range of services such as nursing care,
rehabilitation, and palliative care
▪ They work closely with healthcare professionals, including
nurses and therapists, to provide high-quality care and support
Solutions offered by Roche
➢ Niels Smedegaard - Chair
➢ Board member
➢ Lene Skole - Deputy Chair
➢ Board member
➢ Jakob Riis - President and CEO
➢ Christian Baltzer - CFO
Major Services Offered by Aleris-Hamlet Homecare
Home Healthcare Emergency Medical Services
Assistance Services Occupational Health Services
Health and Safety Solutions Health and Safety Solutions
Telehealth and Digital Solutions Ambulance Services
Medical Transportation Rehabilitation Services
Medical Consulting Chronic Disease Management
Mental Health Services
Press Release/ Recent News
▪ On February 2023, Falck’s first electric ambulance will leave the
station in Copenhagen, Denmark
▪ The electric ambulance will help create valuable experience on how
to convert more ambulances to run on electricity
▪ January 2023, the Swedish occupational healthcare provider,
Previa, rebrands all entities and becomes Falck
▪ Falck is now Sweden’s most comprehensive supplier of services
within health and work life
▪ An apparent strengthening of Falck’s Swedish footprint, building an
even stronger integrated healthcare and career service to private,
public, insurance and business customers across Scandinavia

40
4.2.1 Falck Healthcare (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Falck signs global
agreement with If
Insurance
Collaboration - March 2023
▪ Nordic region's largest player in travel assistance, Falck Global
Assistance, has just entered a new collaboration with one of the
region's largest insurance companies, If Insurance
▪ The new collaboration will ensure that If's customers in Denmark,
Sweden, Norway and Finland can feel secure knowing that Falck
Global Assistance helps with both medical assistance and travel
assistance when they travel around the world
Falck and Swedish
Transport
Administration will
use drones for traffic
overview
Collaboration - April 2023
▪ Emergency and healthcare company, Falck, has just made a new
contract with The Swedish Transport Administration in Stockholm,
Trafikverket, where drones will be used to generate a faster real-
time overview of traffic when road accidents happen, thereby
mitigating queues and intense traffic congestion
▪ Trafikverket and Falck have expanded their collaboration and
now added a new innovative drone solution to assists when
accidents occur on the roads in Stockholm.
Latest Deals - Mergers and Acquisitions

41
4.2.1 Falck Healthcare (continued)
Group Core business areas Portfolio
Falck operates three business
areas; Emergency Health and
Safety, Healthcare and Portfolio
Revenue (USD Mn)
1829.79
Emergency Health and Safety
Comprises the business units
Ambulance Europe, Ambulance
US and Fire services
Revenue (USD Mn)
1120.13
61% share of Group revenue (66%)
Healthcare
Comprises the business units
Employee and Labour Market
services, Consumer and
Technical services and
Community Health services
Revenue (USD Mn)
603.76
Comprises business activities
across patient
transport services and global
travel assistance
Revenue (USD Mn)
117.05
EBITA
(USD Mn) 103.74
EBITA margin 5.7% (12.1%)
EBITA
(USD Mn) 70.17
EBITA margin 6.3% (2021: 15.6%)
EBITA
(USD Mn) 70.75
EBITA
(USD Mn) 0.72
Financial Highlights

42
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.1 Roche (continued)
Revenues ($Bn), 2020-2030
▪ According to Roche's 2020 financial report,
the company had sales of CHF 58.3 Bn
(Swiss Francs) in 2020
▪ This is equivalent to approximately $63.3
Bn USD, based on exchange rates at the
end of 2020
▪ Company's Healthcare Services Division
generated sales of CHF 49.9 Bn in 2020,
while the Diagnostics Division generated
sales of CHF 8.4 Bn
▪ Revenue generated by Roche in 2020
reflects the company's continued growth
and success in the healthcare industry
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

43
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Home
Healthcare
Recent Activity / Press Coverage
Illustrative

44
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

45
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

46
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario

48
5.1 Reimbursement Regulation in Denmark
▪ Municipal responsibility:
Municipalities in Denmark are responsible for organizing and providing home
healthcare services, assessing individuals' needs, and determining the level of support
and reimbursement
▪ Care assessment:
Individuals must undergo a care assessment conducted by the municipality to
determine their medical condition, functional abilities, and support needs, which helps
determine the appropriate level of care and reimbursement
▪ Financial contribution:
Individuals receiving home healthcare may be required to contribute financially based
on their income and assets. The municipality assesses their ability to pay and
calculates the amount of contribution accordingly
▪ Reimbursable services:
Reimbursable home healthcare services may include nursing care, personal care
assistance, rehabilitation, medical equipment, and aids needed for daily living, with
specific coverage varying based on individual needs and municipality guidelines.
▪ Individualized care plan:
Municipalities, together with the individual and their healthcare professionals, develop
an individualized care plan outlining specific services, goals, and duration of home
healthcare. Reimbursement is typically based on the approved care plan
▪ In Denmark, home healthcare
reimbursement regulations are
governed by the Danish Health Act and
the Danish Act on Social Services
▪ These regulations aim to provide
financial support and reimbursement for
eligible individuals who require home
healthcare services
▪ While I can provide a general overview,
it's important to note that specific
details and requirements may vary, and
it's advisable to consult official sources
or relevant authorities for the most up-
to-date and accurate information

49
5.1 Reimbursement Regulation in Denmark(continued)
▪ Coordination of services:
Denmark emphasizes coordination among healthcare and social services to ensure comprehensive and integrated care. This
involves collaboration between the municipality, healthcare providers, and other stakeholders to meet individual needs effectively
▪ Regular assessments:
Home healthcare reimbursement is subject to periodic reassessments by the municipality. The individual's care needs are
reviewed, and the level of reimbursement or services may be adjusted accordingly

50
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
 Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
 Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

51
5.2 Reimbursement Process for Diagnosis in Home Healthcare
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
Illustrative

52
5.3 Reimbursement Process for Treatment in Home Healthcare
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

53
5.4 Reimbursement Process - Medicare
Medicare
Population Covered
▪ 100% population is covered under this scheme
▪ Citizen’s contribute to this scheme which then earns an interest. There is Basic Healthcare Sum (BHS) cap which limits the maximum contribution to an
individuals Medicare account
Provider Restrictions/
Selection
Services can be claimed from Medicare-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, Home Healthcare centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicare and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicare account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicare account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicare up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for Home Healthcare up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal Home Healthcare up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative

54
5.5 Reimbursement Process - Medicaid
Medicaid
Population Covered
▪ 38% population is covered under this scheme
▪ Medicare covers individuals who are aged 65 and older, as well as those with certain disabilities or end-stage renal disease
Provider Restrictions/
Selection
Services can be claimed from Medicaid-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, Home Healthcare centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicaid and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicaid account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicaid account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicaid up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for Home Healthcare up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal Home Healthcare up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Healthcare Services
and healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Healthcare Services
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Denmark
and Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Denmark, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
MDenmarkesh is an engineering
graduate with an MBA in Marketing. He
is a seasoned healthcare market
research & marketing professional with a
progressive experience of over 20 years
in Life Sciences, Pharma and Medical
Device sectors. With an in-depth
understanding of primary research, he
has conducted hundreds of interviews of
various stakeholders in pharma &
healthcare & completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Denmark, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
MDenmarkesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Denmark Home Healthcare Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Denmark Home Healthcare Market Analysis Sample Report

Similar to Denmark Home Healthcare Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Denmark Home Healthcare Market Analysis Sample Report